{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:43:40Z","timestamp":1787697820747,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00247-021-05158-w","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T21:02:48Z","timestamp":1630962168000},"page":"2481-2491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perianal magnetic resonance imaging findings and their potential impact on outcome in children with perianal fistulizing Crohn disease"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-6905","authenticated-orcid":false,"given":"Muhammad Rehan","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel G.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Absah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"5158_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298\u2013306","journal-title":"Nature"},{"key":"5158_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46\u201354.e42","journal-title":"Gastroenterology"},{"key":"5158_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P et al (2011) Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 17:423\u2013439","journal-title":"Inflamm Bowel Dis"},{"key":"5158_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/archdischild-2014-307217","volume":"101","author":"J Kammermeier","year":"2016","unstructured":"Kammermeier J, Morris M, Garrick V et al (2016) Management of Crohn\u2019s disease. Arch Dis Child 101:475\u2013480","journal-title":"Arch Dis Child"},{"key":"5158_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpeds.2010.02.024","volume":"157","author":"O Abramson","year":"2010","unstructured":"Abramson O, Durant M, Mow W et al (2010) Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in northern California, 1996 to 2006. J Pediatr 157:233\u2013239.e1","journal-title":"J Pediatr"},{"key":"5158_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/MIB.0b013e318280b13e","volume":"19","author":"T Adamiak","year":"2013","unstructured":"Adamiak T, Walkiewicz-Jedrzejczak D, Fish D et al (2013) Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 19:1218\u20131223","journal-title":"Inflamm Bowel Dis"},{"key":"5158_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A et al (2002) Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis 8:244\u2013250","journal-title":"Inflamm Bowel Dis"},{"key":"5158_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/ecco-jcc\/jjw039","volume":"10","author":"KB Gecse","year":"2016","unstructured":"Gecse KB, Sebastian S, Hertogh GD et al (2016) Results of the fifth scientific workshop of the ECCO [II]: clinical aspects of perianal fistulising Crohn\u2019s disease \u2014 the unmet needs. J Crohns Colitis 10:758\u2013765","journal-title":"J Crohns Colitis"},{"key":"5158_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/gutjnl-2011-301397","volume":"61","author":"CN Bernstein","year":"2012","unstructured":"Bernstein CN, Loftus EV, Ng SC et al (2012) Hospitalisations and surgery in Crohn\u2019s disease. Gut 61:622\u2013629","journal-title":"Gut"},{"key":"5158_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cgh.2006.06.021","volume":"4","author":"LY Tang","year":"2006","unstructured":"Tang LY, Rawsthorne P, Bernstein CN (2006) Are perineal and luminal fistulas associated in Crohn\u2019s disease? A population-based study. Clin Gastroenterol Hepatol 4:1130\u20131134","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5158_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton TW, Barclay ML, Gearry RB, Frizelle FA (2012) The spectrum of perianal Crohn\u2019s disease in a population-based cohort. Dis Colon rectum 55:773\u2013777","journal-title":"Dis Colon rectum"},{"key":"5158_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.33","volume":"8","author":"M Scharl","year":"2017","unstructured":"Scharl M, Rogler G, Biedermann L (2017) Fistulizing Crohn\u2019s disease. Clin Transl Gastroenterol 8:e106","journal-title":"Clin Transl Gastroenterol"},{"key":"5158_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EV, Tremaine WJ et al (2002) The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology 122:875\u2013880","journal-title":"Gastroenterology"},{"key":"5158_CR14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00247-014-3085-y","volume":"44","author":"G Compton","year":"2014","unstructured":"Compton G, Bartlett M (2014) Perianal disease in pediatric Crohn disease: a review of MRI findings. Pediatr Radiol 44:1198\u20131208","journal-title":"Pediatr Radiol"},{"key":"5158_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2214\/ajr.183.5.1831309","volume":"183","author":"K Horsthuis","year":"2004","unstructured":"Horsthuis K, Stoker J (2004) MRI of perianal Crohn\u2019s disease. AJR Am J Roentgenol 183:1309\u20131315","journal-title":"AJR Am J Roentgenol"},{"key":"5158_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/ecco-jcc\/jjv228","volume":"10","author":"B Siegmund","year":"2016","unstructured":"Siegmund B, Feakins RM, Bamias G et al (2016) Results of the fifth scientific workshop of the ECCO (II): pathophysiology of perianal fistulizing disease. J Crohns Colitis 10:377\u2013386","journal-title":"J Crohns Colitis"},{"key":"5158_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/gut.47.1.63","volume":"47","author":"B von Lampe","year":"2000","unstructured":"von Lampe B, Barthel B, Coupland SE et al (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47:63\u201373","journal-title":"Gut"},{"key":"5158_CR18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1572-0241.2005.40980.x","volume":"100","author":"DB Sachar","year":"2005","unstructured":"Sachar DB, Bodian CA, Goldstein ES et al (2005) Is perianal Crohn\u2019s disease associated with intestinal fistulization? Am J Gastroenterol 100:1547\u20131549","journal-title":"Am J Gastroenterol"},{"key":"5158_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1136\/gut.52.8.1133","volume":"52","author":"A Armuzzi","year":"2003","unstructured":"Armuzzi A, Ahmad T, Ling K et al (2003) Genotype-phenotype analysis of the Crohn\u2019s disease susceptibility haplotype on chromosome 5q31. Gut 52:1133\u20131139","journal-title":"Gut"},{"key":"5158_CR20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2005.10.006","volume":"129","author":"S Vermeire","year":"2005","unstructured":"Vermeire S, Pierik M, Hlavaty T et al (2005) Association of organic cation transporter risk haplotype with perianal penetrating Crohn\u2019s disease but not with susceptibility to IBD. Gastroenterology 129:1845\u20131853","journal-title":"Gastroenterology"},{"key":"5158_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4291\/wjgp.v5.i3.239","volume":"5","author":"R Sordo-Mejia","year":"2014","unstructured":"Sordo-Mejia R, Gaertner WB (2014) Multidisciplinary and evidence-based management of fistulizing perianal Crohn\u2019s disease. World J Gastrointest Pathophysiol 5:239\u2013251","journal-title":"World J Gastrointest Pathophysiol"},{"key":"5158_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA et al (2014) A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease. Gut 63:1381\u20131392","journal-title":"Gut"},{"key":"5158_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1148\/radiol.2016151491","volume":"282","author":"SP Sheedy","year":"2017","unstructured":"Sheedy SP, Bruining DH, Dozois EJ et al (2017) MR imaging of perianal Crohn disease. Radiology 282:628\u2013645","journal-title":"Radiology"},{"key":"5158_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1148\/rg.321115040","volume":"32","author":"CJ de Miguel","year":"2012","unstructured":"de Miguel CJ, del Salto LG, Rivas PF et al (2012) MR imaging evaluation of perianal fistulas: spectrum of imaging features. Radiographics 32:175\u2013194","journal-title":"Radiographics"},{"key":"5158_CR25","doi-asserted-by":"crossref","unstructured":"Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63:1\u201312","DOI":"10.1002\/bjs.1800630102"},{"key":"5158_CR26","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.gastro.2003.08.024","volume":"125","author":"American Gastroenterological Association Clinical Practice Committee","year":"2003","unstructured":"American Gastroenterological Association Clinical Practice Committee (2003) American Gastroenterological Association medical position statement: perianal Crohn\u2019s disease. Gastroenterology 125:1503\u20131507","journal-title":"Gastroenterology"},{"key":"5158_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2214\/ajr.171.2.9694464","volume":"171","author":"JA Spencer","year":"1998","unstructured":"Spencer JA, Chapple K, Wilson D et al (1998) Outcome after surgery for perianal fistula: predictive value of MR imaging. AJR Am J Roentgenol 171:403\u2013406","journal-title":"AJR Am J Roentgenol"},{"key":"5158_CR28","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2019.07.027","volume":"157","author":"P Hindryckx","year":"2019","unstructured":"Hindryckx P, Jairath V, Zou G et al (2019) Development and validation of a magnetic resonance index for assessing fistulas in patients with Crohn\u2019s disease. Gastroenterology 157:1233\u20131244.e5","journal-title":"Gastroenterology"},{"key":"5158_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/apt.14190","volume":"46","author":"MA Samaan","year":"2017","unstructured":"Samaan MA, Puylaert CAJ, Levesque BG et al (2017) The development of a magnetic resonance imaging index for fistulising Crohn\u2019s disease. Aliment Pharmacol Ther 46:516\u2013528","journal-title":"Aliment Pharmacol Ther"},{"key":"5158_CR30","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1007\/s00330-019-6006-5","volume":"29","author":"F Maccioni","year":"2019","unstructured":"Maccioni F, Bencardino D, Buonocore V et al (2019) MRI reveals different Crohn\u2019s disease phenotypes in children and adults. Eur Radiol 29:5082\u20135092","journal-title":"Eur Radiol"},{"key":"5158_CR31","doi-asserted-by":"crossref","unstructured":"Hyams JS, Ferry GD, Mandel FS et al (1991) Development and validation of a Pediatric Crohn\u2019s Disease Activity Index. J Pediatr Gastroenterol Nutr 12:439\u2013447","DOI":"10.1097\/00005176-199105000-00005"},{"key":"5158_CR32","doi-asserted-by":"crossref","unstructured":"Hyams J, Markowitz J, Otley A et al (2005) Evaluation of the Pediatric Crohn Disease Activity Index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 41:416\u2013421","DOI":"10.1097\/01.mpg.0000183350.46795.42"},{"key":"5158_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13244-017-0579-9","volume":"9","author":"JC Gallego","year":"2018","unstructured":"Gallego JC, Echarri A (2018) Role of magnetic resonance imaging in the management of perianal Crohn\u2019s disease. Insights Imaging 9:47\u201358","journal-title":"Insights Imaging"},{"key":"5158_CR34","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1007\/s00330-020-06826-5","volume":"30","author":"S Halligan","year":"2020","unstructured":"Halligan S, Tolan D, Amitai MM et al (2020) ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis. Eur Radiol 30:4734\u20134740","journal-title":"Eur Radiol"},{"key":"5158_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/apt.14190","volume":"46","author":"MA Samaan","year":"2017","unstructured":"Samaan MA, Puylaert CAJ, Levesque BG et al (2017) The development of a magnetic resonance imaging index for fistulising Crohn's disease. Aliment Pharmacol Ther 46:516\u2013528","journal-title":"Aliment Pharmacol Ther"},{"key":"5158_CR36","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1007\/s00330-019-6006-5","volume":"29","author":"F Maccioni","year":"2019","unstructured":"Maccioni F, Bencardino D, Buonocore V et al (2019) MRI reveals different Crohn\u2019s disease phenotypes in children and adults. Eur Radiol 29:5082\u20135092","journal-title":"Eur Radiol"},{"key":"5158_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ecco-jcc\/jjw146","volume":"11","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Oh SH, Kim DY et al (2017) Clinical characteristics and long-term outcomes of paediatric Crohn\u2019s disease: a single-centre experience. J Crohns Colitis 11:157\u2013164","journal-title":"J Crohns Colitis"},{"key":"5158_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ecco-jcc\/jjx130","volume":"12","author":"L Guizzetti","year":"2018","unstructured":"Guizzetti L, Zou G, Khanna R et al (2018) Development of clinical prediction models for surgery and complications in Crohn\u2019s disease. J Crohns Colitis 12:167\u2013177","journal-title":"J Crohns Colitis"},{"key":"5158_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00247-013-2771-5","volume":"44","author":"A Shenoy-Bhangle","year":"2014","unstructured":"Shenoy-Bhangle A, Nimkin K, Goldner D et al (2014) MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol 44:23\u201329","journal-title":"Pediatr Radiol"},{"key":"5158_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijsu.2019.08.003","volume":"69","author":"Z Mei","year":"2019","unstructured":"Mei Z, Wang Q, Zhang Y et al (2019) Risk factors for recurrence after anal fistula surgery: a meta-analysis. Int J Surg 69:153\u2013164","journal-title":"Int J Surg"},{"key":"5158_CR41","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/ecco-jcc\/jjx046","volume":"11","author":"AL Lightner","year":"2017","unstructured":"Lightner AL, Faubion WA (2017) Mesenchymal stem cell injections for the treatment of perianal Crohn\u2019s disease: what we have accomplished and what we still need to do. J Crohns Colitis 11:1267\u20131276","journal-title":"J Crohns Colitis"},{"key":"5158_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","volume":"61","author":"AL Lightner","year":"2018","unstructured":"Lightner AL, Wang Z, Zubair AC, Dozois EJ (2018) A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal Crohn\u2019s disease: progress made and future directions. Dis Colon rectum 61:629\u2013640","journal-title":"Dis Colon rectum"},{"key":"5158_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cgh.2019.07.038","volume":"18","author":"PH Kim","year":"2020","unstructured":"Kim PH, Park SH, Jin K et al (2020) Supplementary anal imaging by magnetic resonance enterography in patients with Crohn\u2019s disease not suspected of having perianal fistulas. Clin Gastroenterol Hepatol 18:415\u2013423.e4","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-021-05158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-021-05158-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-021-05158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T02:08:56Z","timestamp":1637201336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-021-05158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":43,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5158"],"URL":"https:\/\/doi.org\/10.1007\/s00247-021-05158-w","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"30 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Fletcher is a consultant for Takeda, GlaxoSmithKline, Janssen and Boehringer Ingelheim, with funds paid to his institution. He has received grants to his instituion from the Helmsley Charitable Trust, Siemens Healthineers, Takeda and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}